Alyeska Investment Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Alyeska Investment Group’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-212,879	Closed	-$5.75M	–	737
2024 Q2	$5.75M	Buy	212,879 +25,000	+13%	+$493K	0.03%	321
2024 Q1	$4.06M	Buy	+187,879	New	+$4.1M	0.03%	342
2022 Q3	–	Sell	-27,084	Closed	-$84K	–	695
2022 Q2	$84K	Sell	27,084 -35,416	-57%	-$163K	﹤0.01%	558
2022 Q1	$334K	Hold	62,500	–	–	﹤0.01%	559
2021 Q4	$305K	Hold	62,500	–	–	﹤0.01%	578
2021 Q3	$553K	Sell	62,500 -22,860	-27%	-$211K	0.01%	627
2021 Q2	$778K	Sell	85,360 -39,640	-32%	-$395K	0.01%	621
2021 Q1	$2.05M	Buy	+125,000	New	+$2.04M	0.03%	469

Other funds holding LBPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Alyeska Investment Group's LBPH Position: Q3 2024 in Review

Alyeska Investment Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q3 2024, closing a stake of 212,879 shares — an estimated $5.75M sold.

Alyeska Investment Group first reported a position in LBPH in Q1 2021 and held it in 8 quarters. The position peaked at $5.75M in Q2 2024. 125 funds tracked by Wall St. Rank hold LBPH as of Q3 2024.

Alyeska Investment Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Alyeska Investment Group sold 212,879 Longboard Pharmaceuticals, Inc. Common Stock shares in Q3 2024, an estimated $5.75M.
Alyeska Investment Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Alyeska Investment Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $5.75M in Q2 2024.
125 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on Alyeska Investment Group's 13F filing for Q3 2024, filed 14 Nov 2024.